Pain Management Devices Market by Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Neuropathy, Cancer, Facial, MSK, Migraine), Mode of Purchase (OTC, Prescription-based) & Region (NA, Europe, APAC) - Global Forecasts to 2026
[249 Pages Report] The global pain management devices market is projected to reach USD 3.3 billion by 2026 from USD 2.2 billion in 2021, at a CAGR of 8.6% during the forecast period Pain management devices are used to manage chronic and acute pain in patients suffering from various types of disease conditions, such as cancer, neurological disorders, and musculoskeletal disorders, among others. These devices restore the ability to do everyday activities, decrease the need for oral pain medications, and improve the quality of life of patients suffering from these conditions. However, product recalls and high procedural costs likely to challenge market growth in the coming years.
To know about the assumptions considered for the study, Request for Free Sample Report
COVID-19 Impact on the Pain Management Devices Market
The pain management devices market witnessed a loss of business, and the trend continued till late December 2020. Unfavorable changes in regulations and guidelines are hampering the growth of this industry. Major regulatory authorities across the globe (such as CDC, WHO, MHRA, TGA, and EMA) have identified that cancer patients are at greater risk of COVID-19 infection than healthy adults. Thus, screening, diagnostic exams, and surgical procedures are severely restricted or postponed at hospitals and cancer care centers. This is expected to cause disruptions in the pain management devices market. Owing to the factors above, caregivers and hospitals are expected to witness delays in elective surgeries, screening procedures, and neurostimulation procedures. However, the market has gradually risen from the second half of 2020 due to the increase in the number of infusion appointments, ablation procedures among others resulting from efforts to clear backlogs and new cases and fully re-opened healthcare services.
Drivers: Growing number of surgical procedures performed
Over the years, there has been a significant rise in the number of surgical procedures performed across the globe. This can be attributed to the rising geriatric population and the growing prevalence of obesity and other lifestyle diseases. Obesity is one of the key causes of cardiovascular and orthopedic diseases. Analgesia/pain management is the key application area of infusion pumps. Infusion pumps are also widely used for the local administration of narcotic analgesics and anesthetics following bariatric surgery, cardiothoracic surgery, and laparoscopic cholecystectomy.
PCA pumps are used to manage post-operative pain in various orthopedic surgeries such as spine surgeries and in major joint and foot/lower extremity surgical procedures. According to the National Spinal Cord Injury Statistical Center (NSCISC) 2016 datasheet, the annual incidence of spinal cord injuries (SCI) is approximately 54 cases per million population in the US or approximately 17,000 new SCI cases each year. According to the NCBI, more than 51 million inpatient surgical procedures are performed annually in the US alone, and approximately 90% of all hospitalized patients receive medications through IV. With an increase in the number of surgeries performed, the demand for infusion therapy is expected to increase.
Restraints: Product recalls
Pain management devices are used to administer critical fluids, neurostimulations and ablation that involves including high-risk medications. Errors in using these systems can cause serious harm to patients and may even lead to death. According to the Institute of Medicine (US), approximately 1.5 million patients annually experience medication errors costing USD 8,750 per Potential Adverse Drug Event (PADE).
In the past five years, the Emergency Care Research Institute (ECRI) has been pointing out errors in drug administration involving the use of infusion pumps in its Top 10 list of health technology hazards. The recall of these products due to safety and efficacy failures is a key concern for device manufacturers as it affects the sales of pain management devices. These recall activities require manufacturers to replace erroneous device with updated models and compel them to pay for serious injuries in mishaps. Hence, product recalls affect the growth of the overall pain management devices market.
Opportunities: High growth in emerging markets
Emerging economies such as China, India, and Brazil offer significant growth opportunities for players in the pain management devices market. This can primarily be attributed to the diversified healthcare markets in this region, the growing incidence of chronic disorders, and increasing R&D initiatives to develop innovative medical technologies. In addition, infrastructural developments in healthcare facilities, increasing healthcare expenditures, and the low-cost manufacturing advantage offered by emerging countries in the Asia Pacific are expected to encourage market players to invest in this region in the coming years.
Challenges: Use of pain medications as the first line of treatment for pain management
Medication is often the first therapy that doctors use to manage chronic pain. Pain specialists prefer to prescribe medications over devices to patients suffering from pain majorly due to their easy availably, presence of substantial clinical evidence, and lower cost. Usually, physicians opt for pain management devices such as TENS or SCS only if medication and other alternative treatments do not work.
North America holds the largest share in this market
North America dominated the pain management devices market, with a share of 52.3% in 2020, followed by Europe and Asia Pacific. North America is expected to grow at a 7.3% CAGR during the forecast period. North America has been among the frontrunners in developing pain management devices services in the healthcare industry. The market in the US is expected to offer growth opportunities in the coming years owing to the increasing incorporation of pain management devices in the ambulatory care centers. Many major global players are also based in the US, owing to which the country has become a center of innovation in the pain management devices market.
To know about the assumptions considered for the study, download the pdf brochure
Key Market Players
The key players have a strong foothold in the market and offer a wide range of products. Medtronic PLC (Ireland), Boston Scientific (US), Abbott (US), Becton, Dickinson and Company (US), Baxter International (US), B. Braun Melsungen AG (Germany), Stryker (US), Smiths Medical (US), Moog Inc. (US), Avanos Medical, Inc. (US), Nipro Corporation (Japan), Atricure (US), Nevro Corp. (US), Micrel Medical Devices SA (Greece), InfuTronix Solutions LLC (US), Teleflex, Inc. (US), Mindray Medical International Limited (China), Shenzhen MedRena Biotech Co., Ltd. (China), Epic Medical (Singapore), Bioness (US), Microtransponder (US), Neuronano (Sweden), Gimer Medical (Taiwan), Bluewind Medical (Israel), Soterix Medical Inc. (US) and other players.
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Base year considered |
2020 |
|
Forecast period |
2021–2026 |
|
Forecast units |
Value (USD Billion) |
|
Segments covered |
By Type, By Application, By Mode of Purchase, & By Region |
|
Geographies covered |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
|
Companies covered |
The major market players include Medtronic PLC (Ireland), Boston Scientific (US), Abbott (US), Becton, Dickinson and Company (US), Baxter International (US), B. Braun Melsungen AG (Germany), Stryker (US), Smiths Medical (US), Moog Inc. (US), Avanos Medical, Inc. (US), Nipro Corporation (Japan), Atricure (US), Nevro Corp. (US), Micrel Medical Devices SA (Greece), InfuTronix Solutions LLC (US), Teleflex, Inc. (US), Mindray Medical International Limited (China), Shenzhen MedRena Biotech Co., Ltd. (China), Epic Medical (Singapore), Bioness (US), Microtransponder (US), Neuronano (Sweden), Gimer Medical (Taiwan), Bluewind Medical (Israel), Soterix Medical Inc. (US) and other players (Total 25 companies) |
By Type
- Neurostimulation Devices
- Infusion Pumps
- Ablation Devices
By Application
- Neuropathic Pain
- Musculoskeletal Pain
- Cancer Pain
- Facial Pain & Migraine
- Other Applications
By Mode of Purchase
- Prescription
- Over-the-counter
By Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- RoE
- Asia
- Japan
- China
- India
- RoAPAC
- Latin America
- Middle East & Africa
Recent Developments
- In January 2020, Medtronic launched Efficio, a cloud-based data management software, for use with the SynchroMed II intrathecal drug delivery system. This enables clinicians to efficiently manage their targeted drug delivery pump practices to treat patients with chronic pain, cancer, and severe spasticity
- In November 2020, Abbott launched IonicRF Generator a minimally invasive device that uses heat to target specific nerves for chronic pain management.
- In June 2019, Boston Scientific acquired Vertiflex, Inc. (US), a the privately held developer of the Superion Indirect Decompression System, a minimally invasive device used to improve physical functions and reduce pain in patients with lumbar spinal stenosis (LSS).
- In February 2019, Stryker acquired Arrinex (US), a medical device company that developed a novel cryoablation technology, ClariFix, for treating chronic rhinitis.
- In April 2019, Avanos Medical Received the US FDA 0020 501(k) clearance for its ON-Q infusion pump for pain management with Bolus pump. The new ON-Q with Bolus design incorporates improvements that make it simpler and more user-friendly for patients and providers.
Frequently Asked Questions (FAQ):
What is the market size of the pain management devices market?
The global pain management devices market is projected to reach USD 3.3 billion by 2026 from USD 2.2 billion in 2021, at a CAGR of 8.6% during the forecast period.
What are some of the major drivers for this market?
Growing number of surgical procedures performed and increase in the prevalence of chronic diseases. This factor is estimated to drive the market in the coming years.
Who are the major players in the pain management devices market?
Some of the prominent players operating in the pain management devices market are Medtronic PLC (Ireland), Boston Scientific (US), Abbott (US), Becton, Dickinson and Company (US), Baxter International (US), B. Braun Melsungen AG (Germany), Stryker (US).
What is the impact of COVID-19 on the pain management devices market?
The pain management devices market witnessed a loss of business, and the trend continued till late December 2020. Unfavorable changes in regulations and guidelines are hampering the growth of this industry.
Which region has the highest growth potential in the pain management devices market?
North America is expected to dominate the pain management devices market, with a share of 52.3% in 2020 and is expected to register the CAGR of 7.3% during the forecast period. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 30)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.3.3 CURRENCY
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 35)
2.1 RESEARCH APPROACH
2.2 RESEARCH METHODOLOGY DESIGN
FIGURE 1 PAIN MANAGEMENT DEVICES MARKET: RESEARCH DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.2.2.1 Key data from primary sources
2.2.2.2 Key industry insights
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
2.3 MARKET SIZE ESTIMATION
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: MEDTRONIC PLC
FIGURE 7 REVENUE ANALYSIS OF THE TOP FIVE COMPANIES: MARKET (2020)
FIGURE 8 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MARKET (2021–2026)
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 10 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 11 MARKET DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ANALYSIS
2.6 ASSUMPTIONS FOR THE STUDY
2.7 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: PAIN MANAGEMENT DEVICES MARKET
2.8 LIMITATIONS
2.8.1 METHODOLOGY-RELATED LIMITATIONS
2.8.2 SCOPE-RELATED LIMITATIONS
3 EXECUTIVE SUMMARY (Page No. - 50)
FIGURE 12 PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 13 NEUROSTIMULATION MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 14 INFUSION PUMP MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 15 ABLATION DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 16 PAIN RELIEF DEVICES MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 17 PAIN RELIEF DEVICES MARKET, BY MODE OF PURCHASE, 2021 VS. 2026 (USD MILLION)
FIGURE 18 GEOGRAPHIC SNAPSHOT: INFUSION PUMPS MARKET
4 PREMIUM INSIGHTS (Page No. - 56)
4.1 PAIN MANAGEMENT DEVICES MARKET OVERVIEW
FIGURE 19 GROWING DEMAND FOR LONG-TERM PAIN MANAGEMENT AMONG THE GERIATRIC POPULATION—PRIMARY MARKET DRIVER
4.2 ASIA PACIFIC PAIN RELIEF DEVICES MARKET SHARE, BY APPLICATION & REGION (2020)
FIGURE 20 NEUROSTIMULATION TO HOLD THE LARGEST SHARE OF THE ASIA PACIFIC PAIN RELIEF DEVICES MARKET IN 2020
4.3 PAIN RELIEF DEVICES MARKET: GEOGRAPHIC MIX
FIGURE 21 THE US TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
4.4 REGIONAL MIX: PAIN RELIEF DEVICES MARKET
FIGURE 22 NORTH AMERICA DOMINATED THE MARKET IN 2020
5 MARKET OVERVIEW (Page No. - 60)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 23 PAIN MANAGEMENT DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 MARKET DRIVERS
5.2.1.1 Rising demand for chronic pain management in home care settings
5.2.1.2 Growing number of surgical procedures performed
5.2.1.3 Rising prevalence of neurological disorders
5.2.1.3.1 Growing incidence of sports injuries and cancer
TABLE 2 COUNTRY-WISE CANCER INCIDENCE PER MILLION POPULATION, 2015–2019
5.2.1.4 Established reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries
5.2.2 MARKET RESTRAINTS
5.2.2.1 Product recalls
5.2.2.2 High procedural and purchase cost of pain management devices
5.2.3 MARKET OPPORTUNITIES
5.2.3.1 High growth opportunities in emerging countries
TABLE 3 RISING INCOME LEVELS IN EMERGING COUNTRIES
5.2.3.2 Expanding base of pain management clinics/centers across the globe
5.2.3.3 Use of pain medications as the first line of treatment for pain management
5.2.3.4 Stringent regulatory guidelines delay the adoption of novel devices
TABLE 4 PRESENCE OF ALTERNATIVE THERAPIES FOR PAIN MANAGEMENT IS A MAJOR MARKET CHALLENGE
5.3 REGULATORY LANDSCAPE
TABLE 5 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING PAIN MANAGEMENT DEVICES
5.3.1 NORTH AMERICA
5.3.1.1 US
TABLE 6 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 24 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES
5.3.1.2 Canada
FIGURE 25 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
5.3.2 EUROPE
FIGURE 26 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES
5.3.3 ASIA PACIFIC
5.3.3.1 Japan
TABLE 9 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)
5.3.3.2 China
TABLE 10 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.3.3.3 India
FIGURE 27 LATIN AMERICA: REGULATORY SCENARIO
5.3.3.4 Brazil
FIGURE 28 BRAZIL: REGULATORY PROCESS FOR MEDICAL DEVICES
TABLE 11 BRAZIL: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
5.3.3.5 Mexico
FIGURE 29 MEXICO: REGULATORY PROCESS FOR MEDICAL DEVICES
TABLE 12 MEXICO: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS
5.4 VALUE CHAIN ANALYSIS
FIGURE 30 PAIN MANAGEMENT DEVICES MARKET: VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 31 PAIN RELIEF DEVICES MARKET: SUPPLY CHAIN ANALYSIS
5.6 PORTER’S FIVE FORCES ANALYSIS
TABLE 13 PORTER’S FIVE FORCES ANALYSIS
5.6.1 THREAT FROM NEW ENTRANTS
5.6.2 THREAT FROM SUBSTITUTES
5.6.3 BARGAINING POWER OF SUPPLIERS
5.6.4 BARGAINING POWER OF BUYERS
5.6.5 COMPETITIVE RIVALRY
5.7 INDUSTRY TRENDS
5.7.1 WEARABLE DEVICES
5.7.2 RISING POPULARITY OF RECHARGEABLE SPINAL CORD STIMULATORS
5.8 TRADE ANALYSIS
5.8.1 TRADE ANALYSIS FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES
TABLE 14 IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY, 2016–2020 (USD BILLION)
5.9 COVID-19 IMPACT ON THE PAIN MANAGEMENT MARKET
6 PAIN MANAGEMENT DEVICES MARKET, BY TYPE (Page No. - 88)
6.1 INTRODUCTION
TABLE 15 PAIN MANAGEMENT MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.2 NEUROSTIMULATION DEVICES
TABLE 16 NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 17 NEUROSTIMULATION DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) DEVICES
6.2.1.1 Extensive use in healthcare, low cost, and ease of use will favor market growth
TABLE 18 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
6.2.2 SPINAL CORD STIMULATION
6.2.2.1 Rising incidence of indications and efficacy & reversibility of procedure have supported the adoption of SCS
TABLE 19 SPINAL CORD STIMULATION DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
6.3 INFUSION PUMPS
6.3.1 HIGH USE OF INFUSION PUMPS IN POSTOPERATIVE PAIN MANAGEMENT
TABLE 20 INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 21 INFUSION PUMPS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
6.3.2 INTRATHECAL INFUSION PUMPS
TABLE 22 INTRATHECAL INFUSION PUMPS DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
6.3.3 EXTERNAL INFUSION PUMPS
TABLE 23 EXTERNAL INFUSION PUMPS DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
6.4 ABLATION DEVICES
TABLE 24 ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 25 ABLATION DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
6.4.1 RF ABLATION DEVICES
TABLE 26 RF ABLATION DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
6.4.2 CRYOABLATION DEVICES
TABLE 27 CRYOABLATION DEVICES MARKET SIZE, BY REGION,2019–2026 (USD MILLION)
7 PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION (Page No. - 99)
7.1 INTRODUCTION
TABLE 28 PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)
7.2 NEUROPATHIC PAIN
7.2.1 HIGH PREVALENCE OF DISEASES ASSOCIATED WITH NEUROPATHIC PAIN
TABLE 29 NEUROPATHIC PAIN MANAGEMENT MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
7.3 CANCER PAIN
TABLE 30 CANCER PAIN MANAGEMENT MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
7.4 FACIAL PAIN & MIGRAINE
TABLE 31 FACIAL PAIN & MIGRAINE MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
7.5 MUSCULOSKELETAL PAIN
TABLE 32 MUSCULOSKELETAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
7.6 OTHER APPLICATIONS
TABLE 33 OTHER PAIN MANAGEMENT MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
8 PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE (Page No. - 107)
8.1 INTRODUCTION
TABLE 34 PAIN MANAGEMENT MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)
8.2 OVER-THE-COUNTER PAIN MANAGEMENT DEVICES
8.2.1 OTC PAIN MANAGEMENT DEVICES UNFOLD NEW GROWTH AVENUES
TABLE 35 OVER-THE-COUNTER PAIN MANAGEMENT MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
8.3 PRESCRIPTION-BASED PAIN MANAGEMENT DEVICES
TABLE 36 PRESCRIPTION-BASED PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
9 PAIN MANAGEMENT DEVICES MARKET, BY REGION (Page No. - 111)
9.1 INTRODUCTION
FIGURE 32 PAIN RELIEF DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
TABLE 37 GLOBAL PAIN RELIEF DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 33 NORTH AMERICA: PAIN RELIEF DEVICES MARKET SNAPSHOT
TABLE 38 NORTH AMERICA: PAIN RELIEF DEVICES MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 39 NORTH AMERICA: PAIN RELIEF DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 40 NORTH AMERICA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 41 NORTH AMERICA: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 42 NORTH AMERICA: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 43 NORTH AMERICA: PAIN RELIEF DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 44 NORTH AMERICA: PAIN RELIEF DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)
9.2.1 THE US
9.2.1.1 The US is expected to hold the leading position in the market due to the rising geriatric population, increasing prevalence of chronic diseases, and the growing home healthcare market
TABLE 45 KEY MACROINDICATORS FOR THE US
TABLE 46 US: PAIN RELIEF DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 47 US: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 48 US: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 49 US: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 50 US: PAIN RELIEF DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 51 US: PAIN RELIEF DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Increasing incidence of chronic pain indications to support the adoption of pain management devices in Canada
TABLE 52 KEY MACROINDICATORS FOR CANADA
TABLE 53 CANADA: PAIN RELIEF DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 54 CANADA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 55 CANADA: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 56 CANADA: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 57 CANADA: PAIN RELIEF DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 58 CANADA: PAIN RELIEF DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)
9.3 EUROPE
TABLE 59 EUROPE: PAIN RELIEF DEVICES MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 60 EUROPE: PAIN RELIEF DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 61 EUROPE: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 62 EUROPE: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 63 EUROPE: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 64 EUROPE: PAIN RELIEF DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 65 EUROPE: PAIN RELIEF DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Presence of leading pain management device manufacturers to drive market growth in Germany
TABLE 66 KEY MACROINDICATORS FOR GERMANY
TABLE 67 GERMANY: PAIN RELIEF DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 68 GERMANY: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 69 GERMANY: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 70 GERMANY: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 71 GERMANY: PAIN RELIEF DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 72 GERMANY: PAIN RELIEF DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)
9.3.2 FRANCE
TABLE 73 KEY MACROINDICATORS FOR FRANCE
TABLE 74 FRANCE: PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 75 FRANCE: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 76 FRANCE: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 77 FRANCE: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 78 FRANCE: PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 79 FRANCE: PAIN MANAGEMENT MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)
9.3.3 THE UK
9.3.3.1 High burden of chronic pain in the country to propel the growth of the pain management devices market
TABLE 80 KEY MACROINDICATORS FOR THE UK
TABLE 81 UK: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 82 UK: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 83 UK: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 84 UK: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 85 UK: PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 86 UK: PAIN MANAGEMENT MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Growing demand for cost-effective home care services to support market growth
TABLE 87 KEY MACROINDICATORS FOR ITALY
TABLE 88 ITALY: PAIN MANAGEMENT MARKET SIZE, BY TYPE,2019–2026 (USD MILLION)
TABLE 89 ITALY: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 90 ITALY: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 91 ITALY: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 92 ITALY: PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 93 ITALY: PAIN MANAGEMENT MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Rising prevalence of cancer to support the market for pain management devices market in Spain
TABLE 94 KEY MACROINDICATORS FOR SPAIN
TABLE 95 SPAIN: PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 96 SPAIN: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 97 SPAIN: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 98 SPAIN: ABLATION DEVICES MARKET SIZE, BY TYPE,2019–2026 (USD MILLION)
TABLE 99 SPAIN: PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 100 SPAIN: PAIN MANAGEMENT MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 101 ROE: PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 102 ROE: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 103 ROE: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 104 ROE: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 105 ROE: PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 106 ROE: PAIN MANAGEMENT MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 34 ASIA PACIFIC: PAIN MANAGEMENT MARKET SNAPSHOT
TABLE 107 ASIA PACIFIC: PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 108 ASIA PACIFIC: PAIN MANAGEMENT MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 109 ASIA PACIFIC: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 110 ASIA PACIFIC: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 111 ASIA PACIFIC: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 112 ASIA PACIFIC: PAIN MANAGEMENT MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 113 ASIA PACIFIC: PAIN MANAGEMENT MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Large geriatric population in the country is driving the demand for infusion pumps
TABLE 114 KEY MACRO INDICATORS FOR JAPAN
TABLE 115 JAPAN: PAIN RELIEF DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 116 JAPAN: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 117 JAPAN: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 118 JAPAN: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 119 JAPAN: PAIN RELIEF DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 120 JAPAN: PAIN RELIEF DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Growing investments in healthcare infrastructure development in the country to drive market growth in China
TABLE 121 KEY MACRO INDICATORS FOR CHINA
TABLE 122 CHINA: PAIN RELIEF DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 123 CHINA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 124 CHINA: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 125 CHINA: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 126 CHINA: PAIN RELIEF DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 127 CHINA: PAIN RELIEF DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 High prevalence of lifestyle diseases in the country to drive the market for pain management devices market
TABLE 128 KEY MACRO INDICATORS FOR INDIA
TABLE 129 INDIA: PAIN RELIEF DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 130 INDIA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 131 INDIA: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 132 INDIA: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 133 INDIA: PAIN RELIEF DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 134 INDIA: PAIN RELIEF DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
9.4.4.1 High prevalence of chronic diseases in the region to drive the market for pain management devices
FIGURE 35 PREVALENCE OF DIABETES IN SOUTHEAST ASIA (2018/2019)
TABLE 135 ESTIMATED NUMBER OF CANCER CASES IN SOUTHEAST ASIAN COUNTRIES, 2020 VS. 2040 (IN THOUSAND)
FIGURE 36 HEALTHCARE EXPENDITURE (% GDP) IN SOUTHEAST ASIA (2018)
FIGURE 37 GERIATRIC POPULATION IN 2019 (% OF TOTAL POPULATION)
TABLE 136 REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 137 REST OF ASIA PACIFIC: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 138 REST OF ASIA PACIFIC: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 139 REST OF ASIA PACIFIC: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 140 REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 141 REST OF ASIA PACIFIC: PAIN RELIEF DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)
9.5 LATIN AMERICA
TABLE 142 LATIN AMERICA: PAIN RELIEF DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 143 LATIN AMERICA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 144 LATIN AMERICA: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 145 LATIN AMERICA: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 146 LATIN AMERICA: PAIN RELIEF DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 147 LATIN AMERICA: PAIN RELIEF DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)
9.6 MIDDLE EAST AND AFRICA
9.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH
TABLE 148 MIDDLE EAST & AFRICA: PAIN RELIEF DEVICES MARKET SIZBY TYPE, 2019–2026 (USD MILLION)
TABLE 149 MIDDLE EAST & AFRICA: NEUROSTIMULATION DEVICES MARKET SIZE,BY TYPE, 2019–2026 (USD MILLION)
TABLE 150 MIDDLE EAST & AFRICA: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 151 MIDDLE EAST & AFRICA: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)
TABLE 152 MIDDLE EAST AND AFRICA: PAIN RELIEF DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 153 MIDDLE EAST & AFRICA: PAIN RELIEF DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 168)
10.1 OVERVIEW
FIGURE 38 KEY DEVELOPMENTS OF PROMINENT PLAYERS OPERATING IN PAIN MANAGEMENT MARKET (2020-2021)
10.2 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 39 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE PAIN MANAGEMENT DEVICES MARKET
10.3 MARKET SHARE ANALYSIS
FIGURE 40 PAIN MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2020
10.4 COMPANY EVALUATION QUADRANT
10.4.1 STARS
10.4.2 EMERGING LEADERS
10.4.3 PERVASIVE PLAYERS
10.4.4 PARTICIPANTS
FIGURE 41 PAIN MANAGEMENT MARKET: COMPANY EVALUATION QUADRANT (2020)
10.5 COMPANY EVALUATION QUADRANT FOR START-UPS
10.5.1 PROGRESSIVE COMPANIES
10.5.2 DYNAMIC COMPANIES
10.5.3 STARTING BLOCKS
10.5.4 RESPONSIVE COMPANIES
FIGURE 42 PAIN MANAGEMENT MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS (2020)
10.6 COMPANY PRODUCT FOOTPRINT
TABLE 154 PRODUCT PORTFOLIO ANALYSIS: PAIN MANAGEMENT MARKET
10.7 GEOGRAPHIC FOOTPRINT OF THE MAJOR PLAYERS IN THE PAIN MANAGEMENT MARKET
TABLE 155 GEOGRAPHIC REVENUE MIX: PAIN MANAGEMENT MARKET (2020)
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT LAUNCHES
TABLE 156 PRODUCT LAUNCHES (JANUARY 2018 – JUNE 2021)
10.8.2 DEALS
TABLE 157 DEALS (JANUARY 2018–JUNE 2021)
10.8.3 OTHER DEVELOPMENTS
TABLE 158 OTHER DEVELOPMENTS (JANUARY 2018– JUNE 2021)
11 COMPANY PROFILES (Page No. - 184)
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 MEDTRONIC
TABLE 159 MEDTRONIC PLC: BUSINESS OVERVIEW
FIGURE 43 MEDTRONIC PLC: COMPANY SNAPSHOT (2020)
11.1.2 ABBOTT LABORATORIES
TABLE 160 ABBOTT LABORATORIES: BUSINESS OVERVIEW
FIGURE 44 ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 161 ABBOTT LABORATORIES: PRODUCT OFFERINGS
11.1.3 BOSTON SCIENTIFIC CORPORATION
TABLE 162 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
FIGURE 45 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 163 BOSTON SCIENTIFIC CORPORATION: PRODUCT OFFERINGS
11.1.4 STRYKER CORPORATION
TABLE 164 STRYKER: BUSINESS OVERVIEW
FIGURE 46 STRYKER CORPORATION: COMPANY SNAPSHOT
TABLE 165 STRYKER: PRODUCT OFFERINGS
11.1.5 BECTON, DICKINSON AND COMPANY
TABLE 166 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 47 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
11.1.6 B. BRAUN MELSUNGEN AG
TABLE 167 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW
FIGURE 48 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2020)
11.1.7 BAXTER INTERNATIONAL INC.
TABLE 168 BAXTER INTERNATIONAL INC.: BUSINESS OVERVIEW
FIGURE 49 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2020)
11.1.8 AVANOS MEDICAL, INC.
TABLE 169 AVANOS MEDICAL, INC.: BUSINESS OVERVIEW
FIGURE 50 AVANOS MEDICAL, INC.: COMPANY SNAPSHOT (2020)
11.1.9 TELEFLEX, INC.
TABLE 170 TELEFLEX, INC.: BUSINESS OVERVIEW
FIGURE 51 TELEFLEX, INC.: COMPANY SNAPSHOT (2020)
11.1.10 SMITHS MEDICAL
TABLE 171 SMITHS MEDICAL: BUSINESS OVERVIEW
FIGURE 52 SMITHS MEDICAL: COMPANY SNAPSHOT (2020)
11.1.11 NIPRO CORPORATION
TABLE 172 NIPRO CORPORATION: BUSINESS OVERVIEW
FIGURE 53 NIPRO CORPORATION: COMPANY SNAPSHOT (2019)
11.1.12 MOOG INC.
TABLE 173 MOOG INC.: BUSINESS OVERVIEW
FIGURE 54 MOOG INC.: COMPANY SNAPSHOT (2020)
11.1.13 ATRICURE
TABLE 174 ATRICURE: BUSINESS OVERVIEW
FIGURE 55 ATRICURE: COMPANY SNAPSHOT
TABLE 175 ATRICURE: PRODUCT OFFERINGS
11.1.14 NEVRO CORP.
TABLE 176 NEVRO CORP: BUSINESS OVERVIEW
FIGURE 56 NEVRO CORP.: COMPANY SNAPSHOT
TABLE 177 NEVRO CORP: PRODUCT OFFERINGS
11.1.15 MICREL MEDICAL DEVICES SA
TABLE 178 MICREL MEDICAL DEVICES SA: BUSINESS OVERVIEW
11.1.16 MINDRAY MEDICAL INTERNATIONAL LIMITED
TABLE 179 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW
11.1.17 SHENZHEN MEDRENA BIOTECH CO., LTD.
TABLE 180 SHENZHEN MEDRENA BIOTECH CO., LTD.: BUSINESS OVERVIEW
11.1.18 EPIC MEDICAL
TABLE 181 EPIC MEDICAL: BUSINESS OVERVIEW
11.1.19 BIONESS
11.1.20 SOTERIX MEDICAL
11.2 OTHER PLAYERS
11.2.1 INFUTRONIX SOLUTIONS LLC
TABLE 182 INFUTRONIX SOLUTIONS LLC: BUSINESS OVERVIEW
11.2.2 GIMER MEDICAL
11.2.3 BLUEWIND MEDICAL
11.2.4 NEURONANO
11.2.5 MICROTRANSPONDER
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 241)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
This study involved four major activities in estimating the size of the pain management devices market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.
Secondary Research
This research study involved the use of widespread secondary sources, directories, databases (such as Bloomberg Business, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for this extensive, technical, market-oriented, and commercial study of the pain management devices market. It was also used to obtain important information about the key players alongside market classification and segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the pain management devices market. It was also used to obtain important information about key market players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report.
The primary sources from the supply side include CEOs, VPs, managing directors, marketing and sales heads/directors, marketing managers, regional/area sales managers, and pain management devices scientists. Primary sources from the demand side include vice presidents, C-level executives, product managers, department heads, research scientists, research heads, and hospital directors. Other primary respondents include industry experts such as consultants, government, and officials/regulatory authorities.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the pain management devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research
- The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The following figure shows the market validation, source structure, and data triangulation methodology implemented in this report’s market engineering process.
Report Objectives
- To define, describe, and forecast the pain management devices market based type, application, mode of purchase, and region
- To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall pain management devices market
- To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to four main regions, namely,
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. - To profile the key players and analyze their market shares and core competencies
- To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions in the overall pain management devices market
- To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product/service strategy
Available Customizations
MarketsandMarkets offers the following customizations for this market report:
- Additional country-level analysis of pain management devices market
- Profiling of additional market players (up to 3)
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Pain Management Devices Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Pain Management Devices Market
What are the recent developments in the Global Pain Management Devices Market?
I need more details on how global key players are dominating the Pain Management Devices Market. Much Appreciated